MedTrace Logo

The Efficacy of Treadmill Training in Establishing Walking After Stroke

NCT00167531 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 126

Last updated 2009-10-02

No results posted yet for this study

Summary

Being able to walk is a major determinant of whether a patient returns home after stroke or lives in residential care. For the family, the loss of the stroke sufferer from everyday life is a catastrophic event. For the community, the costs of being unable to walk after stroke are exorbitant, involving a lifetime of residential care. Therefore, an increase in the proportion of stroke patients who regain walking ability will be a significant advance.

This trial will determine, in patients early after stroke who are unable to walk, whether training walking using a treadmill with partial weight support via an overhead harness will be more effective than current intervention in (i) establishing more independent walking, reducing the time taken to achieve independent walking, and improving the quality of independent walking, and (ii) improving walking capacity and participation 6 months later.

Conditions

Interventions

BEHAVIORAL

treadmill walking with partial weight support

BEHAVIORAL

assisted overground walking

30 minutes per day of overground walking with the assistance of one therapist

Sponsors & Collaborators

  • University of Sydney

    lead OTHER

Principal Investigators

  • Louise Ada, PhD · University of Sydney

  • Catherine Dean, PhD · University of Sydney

  • Meg Morris, PhD · University of Melbourne

  • Judy Simpson, PhD · University of Sydney

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-08-31
Primary Completion
2009-04-30
Completion
2009-07-31

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00167531 on ClinicalTrials.gov